Business and Finance

Deal bolsters ANI’s generics and CDMO portfolio

More than $600 million in backing opens the door for additional manufacturing capacity, further Covid-19 preparations

Company’s rebranded platform, Ocellos, will manage complex handoffs in cell and gene therapy (CGT) treatments and trials

Agreements to focus on driving adoption of AI and natural language processing for medical affairs programs

The 130,000-square-foot site will be the CDMO's third location

Ten million doses expected by end of Q3

Partnership’s priority is to evaluate mental health medication

Marks the latest big pharma partnership for CureVac around its Covid vaccine candidate, CVnCoV

Drone technology delivers doses to difficult-to-reach locations

In extension of J&J agreement, deal provides manufacturing facilities for Covid-19 vaccine production

Rivals will team up in order to accelerate supply

UK-based OXGENE designs and develops scalable gene therapy technologies

Purchase expands CRO's plans for cell and gene therapy program

Alliance with Jointown comes in time for Covid-19 vaccine storage and distribution efforts

Joins UK consortium to help efficiently manufacture oral solid dosage medication

Deals provide Andlauer Healthcare Group full Skeleton Canada ownership and 49 percent stake in US branch

Supply chain management and logistics company boosts its US presence

Company says it will be able to produce an estimated 12 million doses per month

Pair of agreements expands packaging company's international network

Acquisition is 3PL provider's largest one yet

Acquisition grows Antares’ track-and-trace presence

Strengthens the CRO's scientific capabilities in cell and gene therapy space

Lab development project features 9,000-square-foot expansion

Combine their expertise in immunology and infectious diseases to speed up development of mAbs for influenza

Acquires Scientific Commercialization, a medical affairs consulting and analytics business

PBM's own specialty pharmacy unit adds CareMetx Health, growing its coverage base to the eastern US

Deal will help expand its pharma presence

Becomes a partner in UK consortium focused on enabling new and disruptive manufacturing technologies

UK cell and gene therapy location expected to be cGMP-ready by mid-2022

Will help biomed startups in furthering oncology R&D